Tolero Pharmaceuticals, Inc. — Form D/A
Tolero Pharmaceuticals, Inc. of SALT LAKE CITY, UT, a company, filed a Form D amendment with the SEC on 2014-12-10. The offering totals $35.5M, of which $22.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-12-10
- Form: D/A
- Accession: 0001554907-14-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.5M
- Amount sold: $22.5M
- Remaining: $13.0M
- Investors: 48
- Date of first sale: 2014-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-223152
Issuer
- Name: Tolero Pharmaceuticals, Inc.
- CIK: 0001554907
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 9980 SOUTH 300 WEST SUITE # 200, SALT LAKE CITY, UT, 84070
- Phone: 801-285-7570
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Dallin Anderson | Director | Salt Lake City, UT |
| David Bearss, Ph.D. | Director | Lehi, UT |
| Dallin Anderson | Executive Officer | Salt Lake City, UT |
| David Bearss, Ph.D. | Executive Officer | Lehi, UT |
| Dallin Anderson | Promoter | Salt Lake City, UT |
| David Bearss, Ph.D. | Promoter | Lehi, UT |
| David Bearss | Director | Salt Lake City, UT |
| David Bearss | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (3)
More